http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-1377609-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_232361c9031a709144573276863c462b |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J43-003 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J5-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C- http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K- |
| filingDate | 1970-12-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 1974-12-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | GB-1377609-A |
| titleOfInvention | 3alpha-hydroxy-5alpha-pregnane compounds |
| abstract | 1377609 3α - Hydroxy - 5α - pregnanecompounds GLAXO LABORATORIES Ltd 16 Dec 1971 [17 Dec 1970] 60066/70 Heading C2U [Also in Division A5] Novel 5α-pregnanes possessing a 3α-hydroxy group, a 10-hydrogen atom or methyl group, an 11-oxo group, a 17α-hydrogen atom, a 20-oxo group and at the 21-position a chlorine or iodine atom or a group -XR where XR is O.COR, O.CO.OR, O.CO.SR or O.CO.NHR and R is a nitrobenzyl group, a C 1-6 alkyl group when X is not O.CO, a halogenoalkyl group or a hydrocarbon group substituted by an amino group or a nitrogen-containing heterocyclic group are prepared (a) when the 21-substituent is to be -XR, (i) by esterification of the corresponding 21-ols or steroids possessing a readily eliminatable 21- substituent, with possible protection of the 3α-hydroxy group, e.g. as the nitrate ester, (ii) when R is to be an amino alkyl group, by reacting a corresponding 21-alkanoyloxy steroid containing a readily eliminatable substituent with an appropriate amine, (iii) when R is to be an iodoalkyl group, by reacting a corresponding chloralkyl compound with an iodide, (iv) when R is to be an aryl or aralkyl group substituted by an NH 2 group, by reduction of a corresponding nitro-aryl or -aralkyl compound, (v) when X is to be -OCOS or -OCONH, by reacting a corresponding 21-ol with a carbonyl halide in the presence of an acid binding agent and reacting the product with a thiol RSH or an amine RNH 2 , with intermediate 3-ol protection, or (vi) by stereospecific reduction of the corresponding 3-ones; and (b) when the 21-substituent is to be a Cl or I atom, by reacting a corresponding 21-ol or 21-Br compound with an alkali metal iodide and, when required, reacting the 21-I steroid thus formed with an alkali metal chloride. In process (i) a free NH 2 group may be protected, e.g. as a benzyloxycarbonyl derivative, and subsequently released. Products may be converted into acid-addition salts. 21-Bromo-steroid starting materials are prepared by bromination of the corresponding 21- unsubstituted steroids. 21 - Hydroxy - 3α - nitro - oxy - 5α - pregnane- 11,20-dione is prepared by hydrolysis of the corresponding 21-acetoxy compound, in turn prepared from the free 3α-ol and fuming nitric acid. 21-Hydroxy-2#-methoxy-3α-nitro-oxy-5α- pregnane-11,20-dione is prepared by hydrolysis of the corresponding 21-acetoxy compound, in turn prepared from the 21-bromo compound (prepared by nitration of the free 3α-ol) and potassium acetate. 3α-Hydroxy-2#-methoxy-5α-pregnane-11,20-dione is prepared from 2α,3α-epoxy- 5α-pregnane-11,20-dione and methanol. The novel steroids are anaesthetics, hypnotics and sedatives and they may be made up into pharmaceutical compositions with suitable carriers. |
| priorityDate | 1970-12-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 38.